Peter D. Suzdak
2018
In 2018, Peter D. Suzdak earned a total compensation of $1.3M as Former Chief Executive Officer at Rexahn Pharmaceuticals, a 62% increase compared to previous year.
Compensation breakdown
| Option Awards | $167,999 |
|---|---|
| Salary | $419,931 |
| Other | $713,715 |
| Total | $1,301,645 |
Suzdak received $713.7K in other compensation, accounting for 55% of the total pay in 2018.
Suzdak also received $168K in option awards and $419.9K in salary.
Rankings
In 2018, Peter D. Suzdak's compensation ranked 7,876th out of 14,244 executives tracked by ExecPay. In other words, Suzdak earned more than 44.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,876 out of 14,244 | 45th |
Division Manufacturing | 3,077 out of 5,765 | 47th |
Major group Chemicals And Allied Products | 1,152 out of 2,128 | 46th |
Industry group Drugs | 970 out of 1,817 | 47th |
Industry Pharmaceutical Preparations | 753 out of 1,391 | 46th |
Source: SEC filing on April 29, 2019.
Suzdak's colleagues
We found three more compensation records of executives who worked with Peter D. Suzdak at Rexahn Pharmaceuticals in 2018.